Your browser doesn't support javascript.
loading
Optimizing Salmonella enterica serovar Typhimurium for bacteria-mediated tumor therapy.
Felgner, Sebastian; Kocijancic, Dino; Frahm, Michael; Curtiss, Roy; Erhardt, Marc; Weiss, Siegfried.
Affiliation
  • Felgner S; a Department of Molecular Immunology , Helmholtz Centre for Infection Research , Braunschweig , Germany.
  • Kocijancic D; a Department of Molecular Immunology , Helmholtz Centre for Infection Research , Braunschweig , Germany.
  • Frahm M; a Department of Molecular Immunology , Helmholtz Centre for Infection Research , Braunschweig , Germany.
  • Curtiss R; b Department of Infectious Diseases and Pathology , University of Florida , Gainesville , USA.
  • Erhardt M; c Junior Research Group Infection Biology of Salmonella, Helmholtz Centre for Infection Research , Braunschweig , Germany.
  • Weiss S; a Department of Molecular Immunology , Helmholtz Centre for Infection Research , Braunschweig , Germany.
Gut Microbes ; 7(2): 171-7, 2016.
Article in En | MEDLINE | ID: mdl-26939530

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Salmonella typhimurium / Biological Therapy / Immunotherapy / Neoplasms Limits: Animals / Humans Language: En Journal: Gut Microbes Year: 2016 Type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Salmonella typhimurium / Biological Therapy / Immunotherapy / Neoplasms Limits: Animals / Humans Language: En Journal: Gut Microbes Year: 2016 Type: Article Affiliation country: Germany